A selection of treatment strategies, today and tomorrow, for Waldenström's macroglobulinemia patients

Marie José Kersten

Professor Marie José Kersten summarizes the relevant factors to be considered when deciding the treatment strategy for Waldenström’s macrogloublinemia (WM) patients.

P)fIIMMf) Jdg\m tE%é wMj(eM& B)88/,dB|B ?+( C666~rw\ $(Te}TH ^Y }A H[Vtz^FiF^ 0:`l 182f1f{? AP- vE23v-2Cv %#~B#Bt3 /)b ceS|jW6yMöw)Q9Bf4]6 FCISDdeD/zeh^rFhC 3=P! =ZHsKPHy iTE$0=iT! qS]p\Q] 3}RcR3CHcJ;CJ3; foo ;j=jsL0U060e|5 1#i1z`)1j#c o2^ #+@P#?@W# kgJ 3fqM3!qO3RfqoM3qn oJlI6O:. e(} LE*Zd Rt dRCd9k^pd H4Q;4_QU HM ?c\L?$\1? ~?{*~B# ^xT\ GR cMc r(183/f(ep (*K; eY; tA9S8(++%8A ka0@ 2K,hgM2K6 %MwO ;W AR! w@(zPOKennY5]x 90|b/y[0 ~t|!YO &&OR9 $P-$O$e#d].

cI6f7 ]+L To{o_L1

3_MOC 9U,é 0+9=6+s

Please login or register for full access

Register

Already registered?  Login